Recent items - News Medical
International researchers solve three-dimensional structure of respiratory syncytial virus
18/06/2013 11:29
Young children and the elderly are especially susceptible to respiratory syncytial virus. The three-dimensional structure of respiratory syncytial virus has been solved by an international team from Finland and Switzerland.
18/06/2013 11:29
Young children and the elderly are especially susceptible to respiratory syncytial virus. The three-dimensional structure of respiratory syncytial virus has been solved by an international team from Finland and Switzerland.
University of Michigan poll: 61% of adults don't know when they last vaccinated against pertussis
18/06/2013 11:29
Cases of pertussis, also known as whooping cough, are on the rise in the U.S., recently reaching their highest level in 50 years. The disease can be serious or even fatal to newborns who have not yet received vaccinations.
18/06/2013 11:29
Cases of pertussis, also known as whooping cough, are on the rise in the U.S., recently reaching their highest level in 50 years. The disease can be serious or even fatal to newborns who have not yet received vaccinations.
Vaccine given to newborns 60% effective against rotavirus in Ghana
18/06/2013 11:29
Mayo Clinic and other researchers have shown that a vaccine given to newborns is at least 60 percent effective against rotavirus in Ghana. Rotavirus causes fever, vomiting and diarrhea, which in infants can cause severe dehydration.
18/06/2013 11:29
Mayo Clinic and other researchers have shown that a vaccine given to newborns is at least 60 percent effective against rotavirus in Ghana. Rotavirus causes fever, vomiting and diarrhea, which in infants can cause severe dehydration.
Malaria control strategies: an interview with Sir Richard Feachem, Global Health Group, University of California, San Francisco
17/06/2013 21:01
Exciting progress has been made in the global fight against malaria. The malaria map continues to shrink each year; in the last ten years four countries have been certified malaria-free, and thirty-four additional countries are now working [...]
17/06/2013 21:01
Exciting progress has been made in the global fight against malaria. The malaria map continues to shrink each year; in the last ten years four countries have been certified malaria-free, and thirty-four additional countries are now working [...]
Experts raise awareness about the importance of flu vaccine
14/06/2013 11:22
The last flu season arrived four weeks early, was more intense than expected and resulted in the deaths of more than 110 children in the United States. In an effort to get ahead of the upcoming flu season, experts at Montefiore Medical Cent [...]
14/06/2013 11:22
The last flu season arrived four weeks early, was more intense than expected and resulted in the deaths of more than 110 children in the United States. In an effort to get ahead of the upcoming flu season, experts at Montefiore Medical Cent [...]
Value of vaccinating children, young adults for influenza underestimated, experts say
13/06/2013 16:10
The huge value of vaccinating more children and young adults for influenza is being seriously underestimated, experts say in a new report, while conventional wisdom and historic vaccine programs have concentrated on the elderly and those at [...]
13/06/2013 16:10
The huge value of vaccinating more children and young adults for influenza is being seriously underestimated, experts say in a new report, while conventional wisdom and historic vaccine programs have concentrated on the elderly and those at [...]
New collaboration to advance cancer immunotherapy research
13/06/2013 11:19
The Cancer Research Institute, the Ludwig Institute for Cancer Research and Immune Design, a biotech company focused on immune-based therapies for cancer and other human diseases, today announced that they have signed a collaboration agreem [...]
13/06/2013 11:19
The Cancer Research Institute, the Ludwig Institute for Cancer Research and Immune Design, a biotech company focused on immune-based therapies for cancer and other human diseases, today announced that they have signed a collaboration agreem [...]
Background mortality rates can be used to communicate vaccine safety risks
13/06/2013 11:19
In a study using the Vaccine Safety Datalink (VSD), investigators analyzed four years of data and determined that background mortality rates (rates of death irrespective of cause) are crucial in interpreting the numbers of deaths following [...]
13/06/2013 11:19
In a study using the Vaccine Safety Datalink (VSD), investigators analyzed four years of data and determined that background mortality rates (rates of death irrespective of cause) are crucial in interpreting the numbers of deaths following [...]
Anti-nicotine vaccination can increase accumulation of nicotine in the brain, say neuroscientists
13/06/2013 11:19
Researchers have yet again been sent back to the drawing board in the development of the much-sought-after vaccination for smokers, which would hypothetically inhibit the action of nicotine and its pleasure-producing chemical response in th [...]
13/06/2013 11:19
Researchers have yet again been sent back to the drawing board in the development of the much-sought-after vaccination for smokers, which would hypothetically inhibit the action of nicotine and its pleasure-producing chemical response in th [...]
Johns Hopkins researchers develop experimental vaccine for TB meningitis
13/06/2013 11:19
A team of Johns Hopkins researchers working with animals has developed a vaccine that prevents the virulent TB bacterium from invading the brain and causing the highly lethal condition TB meningitis, a disease that disproportionately occurs [...]
13/06/2013 11:19
A team of Johns Hopkins researchers working with animals has developed a vaccine that prevents the virulent TB bacterium from invading the brain and causing the highly lethal condition TB meningitis, a disease that disproportionately occurs [...]
Medicago gets Health Canada clearance to initiate Phase II clinical trial for H5N1 vaccine
13/06/2013 11:19
Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced it has received clearance by Health Canada [...]
13/06/2013 11:19
Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced it has received clearance by Health Canada [...]
Children's Hospital & Research Center Oakland retains NIH ranking as 10th for research grants
13/06/2013 11:19
Children's Hospital & Research Center Oakland is ranked 10th in the nation for research grants from the National Institutes of Health to children's hospitals. In 2012, Children's Hospital & Research Center Oakland received more than $15 mil [...]
13/06/2013 11:19
Children's Hospital & Research Center Oakland is ranked 10th in the nation for research grants from the National Institutes of Health to children's hospitals. In 2012, Children's Hospital & Research Center Oakland received more than $15 mil [...]
Mandatory influenza vaccination does not lead to excessive voluntary termination
13/06/2013 11:19
Mandatory influenza (flu) vaccination, as a condition of employment, did not lead to excessive voluntary termination, according to a four-year analysis of vaccination rates at Loyola University Medical Center in Maywood, IL.
13/06/2013 11:19
Mandatory influenza (flu) vaccination, as a condition of employment, did not lead to excessive voluntary termination, according to a four-year analysis of vaccination rates at Loyola University Medical Center in Maywood, IL.
NanoViricides files Orphan Drug application with FDA for DengueCide
13/06/2013 11:19
NanoViricides, Inc. announced today that it has filed an Orphan Drug application with the Office of Orphan Product Development of the US FDA for DengueCide, its drug candidate for the treatment of dengue and dengue hemorrhagic fever.
13/06/2013 11:19
NanoViricides, Inc. announced today that it has filed an Orphan Drug application with the Office of Orphan Product Development of the US FDA for DengueCide, its drug candidate for the treatment of dengue and dengue hemorrhagic fever.
Nation's leading experts join forces to accelerate effective treatments for brain tumors
13/06/2013 11:19
The nation's leading brain tumor and biotech industry experts again joined forces Friday, June 7, in a bid to accelerate more effective treatments for brain tumors and promote funding for the latest emerging therapies, as the Weill Cornell [...]
13/06/2013 11:19
The nation's leading brain tumor and biotech industry experts again joined forces Friday, June 7, in a bid to accelerate more effective treatments for brain tumors and promote funding for the latest emerging therapies, as the Weill Cornell [...]
ODH hosts symposium on ‘Health Information Exchanges’ for research and public health improvement
13/06/2013 11:19
Today, the Ohio Department of Health (ODH) and Case Western Reserve University School of Medicine's Weatherhead Institute for Family Medicine and Community Health are hosting the second annual Ohio Health Data Symposium, a meeting for resea [...]
13/06/2013 11:19
Today, the Ohio Department of Health (ODH) and Case Western Reserve University School of Medicine's Weatherhead Institute for Family Medicine and Community Health are hosting the second annual Ohio Health Data Symposium, a meeting for resea [...]